This report combines laboratory and clinical observations, but its measurements do not all point in a single simple direction. Primary study
What was studied
In cultured blood cells from patients with depression, Selank was associated with lower IL-6 gene expression but higher IL-6 concentration in culture medium. The expression effect was not observed in healthy-control cells. A clinical component in anxiety-related diagnoses described changes in circulating immune markers during treatment. Primary report
Our appraisal: avoid the blanket label “anti-inflammatory”
A transcript measurement and a secreted protein measurement answer different questions. Their directions can differ without either being inherently invalid. Interpretation requires sampling times, cell composition, assay methods and the relation between production, release and clearance. One should not select the favorable-sounding direction and omit the other.
The laboratory and clinical components also need their own denominators and comparisons. Cells obtained from one diagnostic population are not interchangeable with serum measurements from another. A useful full-text review would reconstruct which participants contributed to each analysis and whether the same individuals were followed over time.
Changes in a marker panel do not establish better resistance to infection, improved psychiatric symptoms or a desirable immune “balance.” Those are additional outcomes that need direct measurement and an appropriate comparison. Even a correlation between symptoms and markers would not, by itself, identify the marker as the mediator of benefit.
For a research library, the paper's value is the specific biological question it raises: why might expression and extracellular protein differ under these conditions? That question is more accurate and more useful than a broad promise of immune enhancement. Clinical claims require clear allocation methods, prespecified endpoints, effect estimates and harms reporting beyond the abstract-level information available here.
Frequently asked questions
Did IL-6 measures all move together?
No; expression and culture concentration differed in direction.
Were all observations from healthy volunteers?
No.
Does a marker change prove fewer infections?
No.
Is gene expression the same as protein secretion?
No.
Can the clinical and cell results be pooled casually?
No; their designs and populations differ.
Is this proof of immune normalization?
No; that label exceeds the measured outcomes.
What needs fuller review?
Participant flow, controls, assay timing and clinical endpoints.